Tuesday 25 July 2017

How Blockbuster Drugs Fight Off Cheaper Competition

A lower-priced version of blockbuster Remicade hasn’t sold well, will an even cheaper drug upend the obscure pricing of the drug industry?

from WSJ.com: Markets http://ift.tt/2twdDKK
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)